Get Premium to unlock powerful stock data

NYSE:DVA (USA) Healthcare » Healthcare Providers & Services

DaVita Inc $ 111.85 -4.47 (-3.84%)

Volume:

623,033

Avg Vol (1m):

837,155

Market Cap $:

11.40 Bil

Enterprise Value $:

22.82 Bil

PE Ratio:

13.00

PB Ratio:

10.04

Also Trade In: Brazil Germany Mexico UK

EMBED

10Y: -% Above Low: +NaN% Below High: NaN%

Peers

View Full Chart

What is PE Ratio (TTM)?

Current and historical daily P/E ratio for DVA (DaVita Inc) from 1995 to Jan 18 2022. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. DaVita stock (DVA) PE ratio as of Jan 18 2022 is 13. More Details

DaVita PE Ratio (TTM) Chart

EMBED

DaVita PE Ratio (TTM) Historical Data

View and export this data going back to 1995. Start your Free Trial

Total 1218

DaVita PE Ratio (TTM) Historical Data
Date	PE Ratio (TTM) Data	Date	PE Ratio (TTM) Data
2022-01-18	13.0	2021-11-16	11.8
2022-01-17	13.5	2021-11-15	12.4
2022-01-14	13.5	2021-11-12	12.3
2022-01-13	13.4	2021-11-11	12.4
2022-01-12	13.2	2021-11-10	12.4
2022-01-11	13.3	2021-11-09	12.4
2022-01-10	13.2	2021-11-08	12.7
2022-01-07	13.0	2021-11-05	12.7
2022-01-06	13.0	2021-11-04	12.1
2022-01-05	13.3	2021-11-03	12.2
2022-01-04	13.4	2021-11-02	12.1
2022-01-03	13.4	2021-11-01	12.3
2021-12-31	13.2	2021-10-29	12.0
2021-12-30	13.2	2021-10-28	13.3
2021-12-29	13.2	2021-10-27	12.9
2021-12-28	13.1	2021-10-26	13.1
2021-12-27	12.9	2021-10-25	13.3
2021-12-24	13.0	2021-10-22	13.5
2021-12-23	13.0	2021-10-21	13.4
2021-12-22	12.8	2021-10-20	13.3
2021-12-21	12.7	2021-10-19	13.1
2021-12-20	12.5	2021-10-18	13.0
2021-12-17	12.2	2021-10-15	13.1
2021-12-16	12.3	2021-10-14	13.0
2021-12-15	12.2	2021-10-13	12.8
2021-12-14	12.2	2021-10-12	12.9
2021-12-13	12.3	2021-10-11	13.0
2021-12-10	12.3	2021-10-08	13.2
2021-12-09	12.2	2021-10-07	13.3
2021-12-08	12.2	2021-10-06	13.3
2021-12-07	12.0	2021-10-05	13.4
2021-12-06	11.9	2021-10-04	13.5
2021-12-03	11.5	2021-10-01	13.6
2021-12-02	11.5	2021-09-30	13.5
2021-12-01	11.0	2021-09-29	14.1
2021-11-30	11.0	2021-09-28	14.1
2021-11-29	11.3	2021-09-27	16.1
2021-11-26	11.3	2021-09-24	16.1
2021-11-25	11.9	2021-09-23	16.3
2021-11-24	11.9	2021-09-22	16.1
2021-11-23	12.1	2021-09-21	16.0
2021-11-22	12.0	2021-09-20	16.0
2021-11-19	11.6	2021-09-17	16.2
2021-11-18	11.8	2021-09-16	16.2
2021-11-17	11.7	2021-09-15	16.2

DaVita PE Ratio (TTM) Comparison

Company	Market Cap(Mil)	PE Ratio (TTM)

Business Description

Industry

Healthcare » Healthcare Providers & Services » NAICS : 621492 SIC : 8092

Traded in other countries / regions

DVAI34.Brazil TRL.Germany DVA.Mexico 0I7E.UK DVA.USA

Address

2000 16th Street, Denver, CO, USA, 80202

Website

https://www.davita.com

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government ( primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Product

Business

Information

About

Affiliate Program

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Earn affiliate commissions by embedding GuruFocus Charts

GuruFocus Affiliate Program: Earn up to $400 per referral. Detailed

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.